Bio-Rad Laboratories Class B
BIO.B
7 hedge funds and large institutions have $7.84M invested in Bio-Rad Laboratories Class B in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.
37% more capital invested
Capital invested by funds: $5.7M → $7.84M (+$2.14M)
0.02% more ownership
Funds ownership: 0.32% → 0.34% (+0.02%)
0% more funds holding
Funds holding: 7 → 7 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$381K |
| 2 |
Morgan Stanley
New York
|
+$76.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$47.8K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $6.13M | – | – | – |
|
|
2
Renaissance Technologies
New York
| $1.27M | +$381K | +900 | +45% |
|
|
3
Morgan Stanley
New York
| $317K | +$76.2K | +180 | +34% |
|
|
4
UBS Group
Zurich,
Switzerland
| $94K | +$47.8K | +113 | +119% |
|
5
Wells Fargo
San Francisco,
California
| $25K | – | – | – |
|
6
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
BIO.B Hedge Fund Activity: Q2 2020 in Review
7 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q2 2020, worth a combined $7.84M — up 37% from $5.7M a quarter earlier.
Fund positioning in BIO.B was balanced in Q2 2020: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $381K.
- 7 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $7.84M of Bio-Rad Laboratories Class B stock for Q2 2020, up 37% quarter-over-quarter.
- 0 funds opened new Bio-Rad Laboratories Class B positions in Q2 2020 and 0 closed out.
- The largest Bio-Rad Laboratories Class B buyer in Q2 2020 was Renaissance Technologies, an estimated $381K added.
Based on aggregated 13F filings for Q2 2020.